|
|
|
Insider
Information: |
Hallal David |
Relationship: |
Director |
City: |
Cheshire |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
2,885,473 |
|
Indirect Shares
|
17,647,006 |
|
|
Direct
Value |
$39,805,633 |
|
|
Indirect Value
|
$34,240,539 |
|
|
Total
Shares |
20,532,479 |
|
|
Total
Value |
$74,046,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-113.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexion Pharmaceuticals Inc |
ALXN |
CEO, Director |
2016-08-08 |
189,266 |
2014-12-18 |
113,122 |
Premium* |
|
Scholar Rock Holding Corp |
SRRK |
Director |
2019-09-18 |
290,595 |
2019-09-18 |
0 |
Premium* |
|
Allovir Inc |
ALVR |
Director, 10% Owner |
2023-05-11 |
2,108,662 |
2023-05-11 |
17,533,884 |
Premium* |
|
Seer, Inc. |
SEER |
Director |
2023-06-14 |
296,950 |
|
0 |
Premium* |
|
Iteos Therapeutics, Inc. |
ITOS |
Director |
2022-06-09 |
0 |
2021-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
127 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXN |
Alexion Pharmaceuticals I... |
SVP Commercial Ops, Americas |
|
2010-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
14,012 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP. Global Commercial Ops |
|
2011-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
15,646 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,400 |
74,646 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-12-18 |
4 |
A |
$17.98 |
$276,227 |
I/I |
15,363 |
125,041 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
115,575 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
119,965 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
|
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,690 |
128,933 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
|
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,555 |
133,588 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
11,270 |
144,128 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
41,136 |
183,694 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
193,026 |
0 |
- |
|
ALVR |
Allovir Inc |
Chief Executive Officer |
|
2020-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
14,315,700 |
738,153 |
0 |
- |
|
ALVR |
Allovir Inc |
Chief Executive Officer |
|
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
147,000 |
2,230,666 |
0 |
- |
|
SEER |
Seer, Inc. |
Director |
|
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,945 |
273,507 |
0 |
- |
|
ALVR |
Allovir Inc |
Director |
|
2022-07-28 |
4 |
A |
$4.61 |
$15,000,000 |
I/I |
3,253,796 |
16,674,766 |
0 |
- |
|
ALVR |
Allovir Inc |
Director |
|
2023-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
2,108,662 |
0 |
- |
|
SEER |
Seer, Inc. |
Director |
|
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,443 |
296,950 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-07-12 |
4 |
AS |
$120.00 |
$6,000,000 |
D/D |
(50,000) |
89,654 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-10-28 |
4 |
AS |
$122.79 |
$3,691,504 |
I/I |
(30,000) |
88,178 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-10-28 |
4 |
AS |
$122.79 |
$2,214,901 |
D/D |
(18,000) |
88,178 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-12-09 |
4 |
AS |
$127.63 |
$1,366,279 |
D/D |
(10,705) |
109,678 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-12-09 |
4 |
AS |
$127.63 |
$1,868,120 |
I/I |
(14,637) |
109,678 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-12-18 |
4 |
AS |
$127.53 |
$930,331 |
D/D |
(7,295) |
109,678 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Commercial Officer |
|
2013-12-18 |
4 |
AS |
$127.61 |
$1,960,472 |
I/I |
(15,363) |
109,678 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Chief Operating Officer |
|
2014-12-18 |
4 |
AS |
$182.03 |
$1,000,073 |
I/I |
(5,494) |
113,122 |
0 |
- |
|
127 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|